Ocular Disease and Refractive Surgery Residency, 2001, Northeastern State University College of Optometry, Oklahoma, USA Doctor of Optometry, 1996, University of Waterloo, School of Optometry, Canada Bachelor of Science with Honors, 1992, Queen’s University, Canada
Glaucoma, 2011, California State Board of Optometry Lacrimal Dilation and Irrigation 2003 California State Board of Optometry Therapeutic 2001 California State Board of Optometry Laser Therapy for Anterior Segment 2000 State Board of Oklahoma in Optometry
Chief of Optometric Staff, Associate Professor – August 2017 to present Eye Care Institute, Western University of Health Sciences, College of Optometry (WUCO) Clinical Director – August 2007 to August 2017 Jenkins Eye Care (referral practice that specializing in refractive corneal and cataract surgeries, and glaucoma laser and surgical procedures), Honolulu, Hawaii Assistant Professor – July 2001 to June 2007 Southern California College of Optometry, Fullerton, California Clinic faculty for the primary care and ocular disease departments Clinic Coordinator for the Eye Care Service at Cerritos College Lecturer in Clinical Medicine, Ocular Health Procedures II & III, and Geriatrics courses Instructor of record for courses Ocular Disease Case Management (2002 to 2007) and Ocular Health Procedures II (2005 to 2007) Associate Optometrist – September 1996 to June 2000 New Westminster Family Eye Care Center, New Westminster, British Columbia Associate Optometrist – January to September 1999 Dr. Paul Clark and Associates, Terrace, British Columbia Associate Optometrist – September 1996 to December 1998 Dr. John Hsiao and Associates, Richmond, British Columbia Staff Clinical Supervisor – May to September 1996 School of Optometry, University of Waterloo, Waterloo
Eye Care Institute, Pomona, CA, Chief of Optometric Staff
Public health; Anti-biotic Resistance, Laser and Minor Surgeries in Eye Care, Refractive Corneal and Cataract Surgery
Taught numerous ocular disease and refractive surgery management courses.
PPO 6: Introduction to Surgical Eye Care
Anti-biotic resistance in eye care; dry eye disease diagnosis and treatment, refractive corneal and cataract surgery outcome management.
Shire Pharmaceuticals. A phase 3, multi-center, randomized, double-masked study to evaluate the clinical efficacy and safety of SHIP640 ophthalmic suspension compared to PVP-Iodine and placebo in the treatment of adenoviral conjunctivitis. Sub-Investigator and Site Director, March 2017 to August 2017 Shire Pharmaceuticals. A phase 3, multi-center, randomized, double-masked study to evaluate the clinical efficacy and safety of SHIP640 ophthalmic suspension compared to placebo in the treatment of bacterial conjunctivitis. Sub-Investigator and Site Director, March 2017 to August 2017. Advances Vision Research/Akorn. Evaluation of tear osmolarity over time with sustained use of TheraTears lubricating drops (Bentley). Principal Investigator, March 2014 to 2017 Icon BioScience Inc. A multicenter, randomized, double-masked, dose-ranging, phase 2 study to evaluate the efficacy and safety of IBI-10090 for the treatment of inflammation associated with ocular surgery. Sub-Investigator, March 2012 – March 2013. Alcon Laboratories and Wavetec Vision. Accuracy and predictability of using Optiwave in the alignment of toric implantable intraocular lenses. Sub-Investigator, 2013. Vistakon, Division of Johnson &Johnson Vision Care Inc. Pilot evaluation of Narafilcon B on a Japanese Population. Principal Investigator, 1 of 3 sites in multicenter clinical trial. December 2010 to February 2011. Santen Pharmaceuticals. FDA Phase I &II study of a glaucoma medication. Sub-Investigator, private ophthalmology practice, 1 of 5 sites in multicenter clinical trial, March 2009 to April 2010. Alcon Laboratories. Effectiveness of aberrometry in assessing corneal stability in de-adapting contact lens photorefractive candidates. Principal Investigator, SCCO as sole site, December 2003 to February 2004 Rose Stone Enterprises. A clinical study comparing fluorexon and sodium fluorescein in combination with benoxinate for use in Goldmann tonometry. Principal Investigator, SCCO as sole site, November 2003-June 2004 Alcon Laboratories. LASIK flap position and post-LASIK dry eye. Sub-Investigator, SCCO as sole site, December 2001 - December 2002. Alcon Laboratories. An evaluation of the safety and efficacy of moxifloxacin ophthalmic solution 0.5% versus non-preserved vehicle in the treatment of bacterial conjunctivitis. Phase III FDA multi-investigator national study. Sub-Investigator, SCCO. July - December 2002 Fund for Improvement in Post-Secondary Education (FIPSE). Basic and Clinical Integration Curriculum (BACIC). Sub-Investigator, SCCO was 1 of 3 sites national, July 2000 – July 2004
Fellow of the American Academy of Optometry
Member of the American Optometric Association
Reviewer for Optometry and Vision Science (OVS) Journal
Reviewer for Council on Optometric Practitioner Education (COPE)
Vice President – 2016 – 2017. The Movement Center (Nonprofit performing arts program), Honolulu, HI Project Vision – 2011 - 2017. Mobile vision and retinal screening, Honolulu, HI Diabetic Retinopathy – Jun 5, 2010. American Diabetes Association, Honolulu, HI Vision and Vitality – March 2009. Olivet Baptist Church, Honolulu, HI Vision Screening for Cambodian orphans - September 2008, Honolulu, HI Vision and Vitality – July 2008. Waikiki Community Center, HI Student Research Symposium – May 2007. Judge, Fullerton, CA Missionary Optometrist – May 2005. Vision and Health Mission, Cusco, Peru What is Optometry? – March 8, 2005. Guest Speaker for Pharmacy Technician Association at Cerritos Special Olympics: Opening Eyes Program. Volunteer Optometrist, Honolulu, HI – 2003 to present Adventures in Science – June 2004. Guest Presenter for Fullerton School District, Fullerton, CA Bridges to Tomorrow: Math/Science Conference for Girls – January 2003. Guest Speaker, Fullerton, CA Missionary Optometrist – February 1998. Third World Eye Care Society, Grenada, West Indes
Ng, LT, Jenkins, TL, Nguyen, AL. Comparing refractive cataract surgery methods. Optometry Times. October 2014: Vol 6, No 10. Ng, L. Co-managing cataract surgery patients has its advantages. Optometry Times. September 2012; 25. Ng, LT, Myung, E, Nguyen, AL. Effectiveness of Various Technologies in Assessing Corneal Stability in De-adapting Soft Contact Lens Photorefractive Candidates. Optom Vis Sci May 2005. Ng, LT, Tong, JW, DeLand, PN. The Validity of Fluorexon Disodium Versus Sodium Fluorescein for use in Goldmann Tonometry. Cornea, July 2006, 25(6):679-86.
Dr. Loretta Ng is a clinician, an educator and a researcher. She graduated from the University of Waterloo, School of Optometry in 1996 and began private practice in Vancouver, BC before moving to the US to do a refractive/disease residency in Oklahoma. She joined the ocular disease faculty at Southern California College of Optometry (Marshal Ketchum University) in 2001 and spent 6 years publishing her own research and educating future optometrists. In 2007 she moved to Hawaii to become the clinical director of Jenkins Eye Care, a busy ophthalmology practice in Honolulu. In August 2017, she joined Western University College of Optometry as Chief of Optometric Staff and enjoys being back in academia. She maintains involvement in clinical research and lectures nationally and internationally. In her free time she enjoys spending time outdoors with her son and husband.